Agilent and ExonHit Enters into Marketing Alliance
News Jun 01, 2006
Agilent Technologies Inc. and ExonHit Therapeutics have announced that they have entered into a marketing alliance in which Agilent will market and sell nine different ExonHit human and mouse SpliceArrays as commercial products.
These SpliceArrays include GPCR, Ion Channel, nuclear receptors and apoptosis pathways.
"Splice variant analysis is the next natural development in gene-expression technology, and we see it as holding important value for the biomedical research community," said Fran DiNuzzo, Agilent vice president and general manager, Integrated Biology Solutions.
"SpliceArray technology also complements our portfolio of microarray-based research tools, and the ExonHit team has proven to be a source of well-designed solutions."
"We are excited to take this step, which broadens the relationship between our companies," said Bruno Tocque, president of ExonHit's Management Board.
"Agilent is a technology and market leader in the field of microarrays, and we are very pleased to be partners with them in the broader commercialization of this new generation of microarrays."
ExonHit SpliceArrays originally became available through Agilent in August 2005, and based on the success of that collaboration, the two companies expanded the agreement.
3-D Printed Sugar Scaffolds Offer Sweet Solution for Tissue EngineeringNews
University of Illinois engineers built a 3-D printer that offers a sweet solution to making detailed structures that commercial 3-D printers can’t: Rather than a layer-upon-layer solid shell, it produces a delicate network of thin ribbons of hardened isomalt, the type of sugar alcohol used to make throat lozenges.READ MORE
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018